NCT02274974View on ClinicalTrials.gov

Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Pain, Postoperative
Interventions
DRUG

Lidocaine

•The wound of C.Swill be infiltrated before closure of the skin, with 20 ml of 2% lidocaine.

DRUG

lidocaine and Epinephrine

The wound of C.S will be infiltrated before closure of the skin, with 20 ml of 2% lidocaine and epinephrine in related dose manner 1:200.000.

Trial Locations (1)

11511

Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER

NCT02274974 - Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine | Biotech Hunter | Biotech Hunter